Susan E. Morano - May 9, 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Director
Signature: /s/ Susan Thompson, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: May 9, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/13/2024, 04:37 PM
Previous filing: Jul 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Award	$0	+1.45K	+69.64%	$0.00	3.53K	May 9, 2024	Direct	F1
transaction	BSX	Common Stock	Award	$0	+421	+11.92%	$0.00	3.95K	May 9, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Award	$0	+1.45K	+69.64%	$0.00	3.53K	May 9, 2024	Common Stock	1.45K		Direct	F3, F4
transaction	BSX	Deferred Stock Units	Award	$0	+421	+11.92%	$0.00	3.95K	May 9, 2024	Common Stock	421		Direct	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $107,500 (representing 50% of the amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.
F2	Grant of restricted stock in lieu of 25% yearly cash compensation. Reflects a value of approximately $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.
F3	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4	Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $107,500 (representing 50% of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.
F5	Deferred stock units were granted in lieu of 25% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.